Titlebook: Radiotherapy of Liver Cancer; Jinsil Seong Book 2021 Springer Nature Singapore Pte Ltd. 2021 radiation therapy for liver tumors.radiothera

只看該作者 · 發(fā)表于 2025-3-23 10:34:19

Gi Hong Choicer research. In particular, new approaches to both .Personalized Cancer Medicine. and .Targeted Therapies. have made promising progress. While the Second Edition featured scholarly contributions from approxima978-3-642-27841-9

只看該作者 · 發(fā)表于 2025-3-23 16:15:14

只看該作者 · 發(fā)表于 2025-3-23 19:27:28

fields. This work has come to fruition by making use of the expert academic input from the extraordinarily rich population of current and past editorial board members and section editors of and contributors to the Journal of Business Ethics..978-3-319-23514-1

只看該作者 · 發(fā)表于 2025-3-23 22:51:11

Victor Ho-Fun Lee,Anne Wing-Mui Leeal cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both .Personalized Cancer Medicine. and .Targeted Therapies. have made promising progress. While the Second Edition featured scholarly contributions from approxima

只看該作者 · 發(fā)表于 2025-3-24 02:23:59

Jun Yong Parkal cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both .Personalized Cancer Medicine. and .Targeted Therapies. have made promising progress. While the Second Edition featured scholarly contributions from approxima

只看該作者 · 發(fā)表于 2025-3-24 09:03:10

只看該作者 · 發(fā)表于 2025-3-24 11:35:02

al cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both .Personalized Cancer Medicine. and .Targeted Therapies. have made promising progress. While the Second Edition featured scholarly contributions from approxima

只看該作者 · 發(fā)表于 2025-3-24 18:50:49

Naoko Sanuki,Atsuya Takeda,Yuichiro Tsurugaial cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both .Personalized Cancer Medicine. and .Targeted Therapies. have made promising progress. While the Second Edition featured scholarly contributions from approxima

只看該作者 · 發(fā)表于 2025-3-24 20:57:56

只看該作者 · 發(fā)表于 2025-3-25 00:51:31

Sang Min Yoonal cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both .Personalized Cancer Medicine. and .Targeted Therapies. have made promising progress. While the Second Edition featured scholarly contributions from approxima

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-29 14:43
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved